HOME >> MEDICINE >> NEWS
Stanford researcher links hot flashes to insomnia

Stanford, Calif. - Millions of women experience menopause each year, and many find themselves having to cope with a plethora of unpleasant symptoms. Hot flashes, headaches and mood swings all come with the territory and, for some women, so does insomnia.

Maurice Ohayon, MD, PhD, DSc, associate professor of psychiatry and behavioral sciences and director of sleep epidemiology at the Stanford University School of Medicine, recently sought to determine the factors that contribute to insomnia among these midlife women. Below is a snapshot of his research findings, which will appear in the July 26 issue of the Archives of Internal Medicine.

The question:
To what extent can hot flashes in midlife women be considered a cause of chronic insomnia?

The background:
Because hot flashes may occur during the night, their presence has been frequently associated with insomnia; however, many other factors can be responsible for insomnia. These include anxiety and depression, which often occur during menopause, and sleep apnea or other sleep disorders, which become more common with age.

The study:
Researchers conducted telephone interviews with 982 women, ages 35 to 65, about their sleep history, hot flashes and overall health status. Chronic insomnia was defined as having difficulty getting to sleep or staying asleep at least three nights a week for the past six months or more. Hot flashes were evaluated on their frequency, severity and daytime functioning. The results were controlled for the presence of variables generally associated with insomnia.

The findings:
The overall prevalence of hot flashes was 79 percent in perimenopausal women (having at least one menstrual cycle in the past 12 months) and 51 percent in postmenopausal women (no menstrual cycles in the past year) - figures that are consistent with those from previous studies. The prevalence of insomnia was 57 percent in perimenopausal women an
'"/>

Contact: Michelle Brandt
mbrandt@stanford.edu
Stanford University Medical Center
26-Jun-2006


Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Old McDonalds has a hold on kids taste buds, Stanford/Packard study finds
3. Aging stem cells in mice may hold answers to diseases of the aged, Stanford study finds
4. Stanford researchers track human stem cells transplanted into rat brain
5. Once-fatal metabolic disorders treatable, says Stanford/Packard researcher
6. Tiny newborns face higher risk of death at community hospitals, Stanford/VA study finds
7. Star Trek-type scanning may reveal genetic activity of tumors, Stanford study shows
8. Scavenger cells may have role blocking obesity, Stanford study shows
9. Stanford researchers identify immune dysfunction in melanoma patients
10. Eye diseases gave great painters different vision of their work, Stanford ophthalmologist says
11. IADR presents Research in Prosthodontics & Implants Award to Stanford

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Stanford researcher links hot flashes insomnia

(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and ... to treat specific body parts and muscle groups. , ... to use patented cold therapy machine with the innovative IsoTube ... muscle injuries. IsoComforter has become the industry leader in ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
(Date:1/22/2015)... 2015 As interest in the value of ... momentum worldwide, Rev. Eric J. Hall , president and ... (HCCN), will be the keynote speaker on January 27 at ... health system. , The conference, “Hope and Resilience: Innovative and ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Compare-autoinsurance.org has released a ... insured by an auto insurance policy . , Some ... policy. Clients should check the newly released blog post to see ... cars and dangerously damaged vehicles are some of the cars that ...
(Date:1/22/2015)... VA (PRWEB) January 22, 2015 Step ... power at the Science Museum of Virginia. Wicked Plants, ... , Wicked Plants unearths 75 poisonous, carnivorous and diabolical ... through each room to uncover the biochemical, physical and ...
Breaking Medicine News(10 mins):Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. today ... Inc. for the compounding, packaging and distributing of its naltrexone ... the United States . KRS ... compounding naltrexone tablets in various strengths for individual patients in ...
(Date:1/23/2015)... 23, 2015  HyGreen, Inc., a leader in hand hygiene ... RCA Medical, a subsidiary of Ascendis Health Limited, in ... Each year, hundreds of millions of patients around the ... are transmitted from patient to patient via the unwashed ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
Cached News: